Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 70 | 10 | 10 | 30 | 60 |
| Receivables | 10 | 9 | 10 | 20 | 100 |
| Inventories | 3 | N/A | N/A | N/A | N/A |
| Other current assets | 8 | 11 | 10 | 0 | 10 |
| TOTAL | $90 | $30 | $30 | $50 | $170 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $10 | $10 | $10 | $10 | $10 |
| Total Assets | $130 | $70 | $70 | $100 | $230 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $790 | $810 | $670 | $620 | $510 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $2,290 | $2,310 | $2,170 | $2,120 | $2,010 |
| Shareholders' Equity | |||||
| Common Shares | 130 | 130 | 130 | 130 | 130 |
| Retained earnings | -19,930 | -19,950 | -19,800 | -19,660 | -19,420 |
| Other shareholders' equity | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $-2,630 | $-2,710 | $-2,560 | $-2,470 | $-2,230 |
| Total Liabilities And Equity | $-340 | $-400 | $-390 | $-350 | $-220 |